Data for ST003321   

(Analysis AN005435): Average values per metabolite and experimental factor (Units:relative units)

Metabolite structureAll dataF1F2F3F4F5F6F7F8F9
PC(16:0/16:0)
19.42 19.10 13.64 13.76 20.88 11.26 16.83 18.81 21.88
PC(16:0_16:1)
4.92 7.26 5.99 6.15 4.86 4.49 3.83 3.60 4.33
PC(16:0_18:1)
30.38 22.14 17.60 19.21 27.77 21.82 23.42 23.72 29.49
PC(16:0_20:3 n-6)
0.34 0.37 0.48 0.57 0.39 0.79 0.60 0.37 0.32
PC(16:0_20:3 n-9)
2.48 2.24 4.68 4.81 2.83 3.62 4.01 2.76 2.25
PC(16:0_20:4)
2.57 0.81 2.16 2.75 3.68 3.69 4.01 2.97 3.60
PC(16:0_22:5)
0.91 0.24 0.67 0.81 1.12 0.95 1.07 1.30 1.14
PC(16:0_22:6)
0.32 0.16 0.34 0.45 0.41 0.33 0.47 0.48 0.40
PC(16:1_18:1)
5.37 10.80 7.67 8.23 5.61 8.06 6.36 5.94 5.40
PC(18:0_18:1)
11.44 10.85 13.14 11.51 9.42 11.91 9.83 13.77 11.17
PC(18:0_20:3 n-6)
0.46 0.11 0.27 0.31 0.27 0.32 0.33 0.54 0.54
PC(18:0_20:3 n-9)
0.93 0.31 0.53 0.57 0.37 0.66 0.69 0.68 0.47
PC(18:0_20:4)
2.06 0.29 1.12 1.43 1.60 1.93 1.99 2.08 1.86
PC(18:0_22:5)
0.50 0.08 0.26 0.31 0.33 0.31 0.50 0.76 0.55
PC(18:0_22:6)
0.33 0.10 0.32 0.33 0.23 0.21 0.40 0.55 0.35
PC(18:1/18:1)
12.79 23.25 26.17 23.07 14.19 22.84 17.60 15.89 10.90
PC(18:1_18:2)
1.27 0.42 0.85 0.88 1.26 0.95 0.81 0.78 1.37
PC(18:1_20:3 n-6)
0.49 0.25 0.65 0.71 0.68 0.71 0.70 0.56 0.60
PC(18:1_20:3 n-9)
0.33 0.31 0.47 0.54 0.36 0.71 0.65 0.42 0.29
PC(18:1_20:4)
2.09 0.60 2.15 2.65 2.98 3.69 4.68 2.90 2.47
PC(18:1_22:5)
0.39 0.18 0.41 0.52 0.49 0.48 0.76 0.66 0.39
PC(18:1_22:6)
0.22 0.12 0.40 0.41 0.27 0.29 0.46 0.46 0.24

Factors:

F1treatment:CHX | treatment:TOFA
F2treatment:DMSO | treatment:-
F3treatment:DMSO | treatment:TOFA
F4treatment:ETO | treatment:TOFA
F5treatment:MCA | treatment:TOFA
F6treatment:Serum | treatment:TOFA
F7treatment:STS | treatment:TOFA
F8treatment:TPG | treatment:TOFA
F9treatment:VAL | treatment:TOFA
  logo